FCM
Farallon Capital Management Portfolio holdings
AUM
$15.3B
1-Year Est. Return
51.42%
This Fund
S&P 500
1 Year Est. Return
+51.42%
AUM
$15.3B
AUM Growth
-$2.87B
(-16%)
Holding
201
Top Buys
| 1 | +$292M | |
| 2 | +$280M | |
| 3 | +$248M | |
| 4 |
Mastercard
MA
|
+$138M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$133M |
Top Sells
| 1 | +$650M | |
| 2 | +$470M | |
| 3 | +$334M | |
| 4 |
Nasdaq
NDAQ
|
+$290M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$233M |
Sector Composition
| 1 | Healthcare | 57.82% |
| 2 | Financials | 13.96% |
| 3 | Technology | 12.78% |
| 4 | Consumer Discretionary | 5.83% |
| 5 | Industrials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$33.2B
| $1.32B | 8.62% |
13,604,796
-978,000
|
|
||
2
Amazon
AMZN
$2.69T
| $879M | 5.73% |
4,218,394
-281,500
|
|
||
3
Microsoft
MSFT
$3.17T
| $868M | 5.66% |
2,344,779
+130,700
|
|
||
4
Aon
AON
$67.9B
| $811M | 5.29% |
2,512,638
-152,600
|
|
||
5
BridgeBio Pharma
BBIO
$12.5B
| $695M | 4.53% |
9,365,463
+367,000
|
|
||
6
Protagonist Therapeutics
PTGX
$6.14B
| $669M | 4.36% |
6,348,906
+204,900
|
|
||
7
Natera
NTRA
$30.5B
| $641M | 4.18% |
3,207,366
-707,000
|
|
||
8
Exelixis
EXEL
$12.2B
| $562M | 3.67% |
13,111,010
-2,598,490
|
|
||
9
Broadcom
AVGO
$2.27T
| $551M | 3.59% |
1,779,500
+887,100
|
|
||
10
UnitedHealth
UNH
$342B
| $493M | 3.21% |
1,821,706
+222,800
|
|
||
11
Synopsys
SNPS
$95.4B
| $481M | 3.14% |
1,213,300
+214,100
|
|
||
12
Boston Scientific
BSX
$70.9B
| $469M | 3.06% |
7,470,684
+31,120
|
|
||
|
13
Thermo Fisher Scientific
TMO
$179B
| $433M | 2.82% |
881,485
+245,800
|
|
||
14
KKR & Co
KKR
$84.8B
| $432M | 2.82% |
4,671,800
+2,654,100
|
|
||
15
Lantheus
LNTH
$6.53B
| $424M | 2.76% |
5,583,479
+156,000
|
|
||
16
Wabtec
WAB
$44.9B
| $402M | 2.62% |
1,609,403
-866,600
|
|
||
17
Charles Schwab
SCHW
$151B
| $372M | 2.42% |
3,955,657
+616,000
|
|
||
18
Liquidia Corp
LQDA
$4.9B
| $327M | 2.13% |
8,656,038
|
|
||
19
Crinetics Pharmaceuticals
CRNX
$3.44B
| $303M | 1.97% |
8,338,098
+1,405,000
|
|
||
20
Alphabet (Google) Class C
GOOG
$4.31T
| $286M | 1.86% |
996,231
+209,191
|
|
||
21
Roivant Sciences
ROIV
$20.6B
| $268M | 1.75% |
9,675,000
+9,638,000
|
|
||
22
Visa
V
$594B
| $254M | 1.66% |
840,710
+144,800
|
|
||
23
Aramark
ARMK
$14.2B
| $249M | 1.62% |
6,135,431
-3,221,615
|
|
||
24
Beam Therapeutics
BEAM
$3.04B
| $242M | 1.57% |
10,134,696
+71,585
|
|
||
25
Walt Disney
DIS
$173B
| $231M | 1.51% |
2,401,591
-1,724,400
|
|